Nanomedicine News

RSS

Fourth International Nanomedicine Conference Being Hosted by UNSW CAN

The Australian Centre for Nanomedicine (ACN) at UNSW is hosting the fourth International Nanomedicine Conference from 1 – 3 July in Sydney.

25 Jun 2013

New Ways to Maximize Delivery of RNA Strands Carried by Nanoparticles

Nanoparticles that deliver short strands of RNA offer a way to treat cancer and other diseases by shutting off malfunctioning genes. Although this approach has shown some promise, scientists are still not sure exactly what happens to the nanoparticles once they get inside their target cells.

From Massachusetts Institute of Technology 25 Jun 2013

Nanoprobes Detect Specific Genetic Materials from Human Samples

Duke University biomedical engineers and genome researchers have developed a proof-of-principle approach using light to detect infections before patients show symptoms.

24 Jun 2013

New Report on Leaders in Smart Pills Technologies Market

Research and Markets has announced the addition of the "Smart Pills Technologies Market (2012-2017) (Diagnostic imaging, patient monitoring, drug delivery)" report to their offering.

From Research and Markets 21 Jun 2013

Undergraduate Nanobiotechnology Researchers Receive Research Fellowship

Collagen, Raman-tweezers and nanotechnology are all well-known words for three Appalachian State University undergraduate physics majors.

21 Jun 2013

CNSE and Nuclea Partner to Develop Nanochips for Cancer Diagnosis and Treatment

Underscoring the strategic blueprint of Governor Andrew M. Cuomo in fueling New York’s growing reputation as a hub for nanotechnology-enabled innovation, SUNY’s College of Nanoscale Science and Engineering (CNSE) and Pittsfield, Massachusetts-based Nuclea Biotechnologies, Inc. (Nuclea) today announced the launch of a $1 million research partnership to enable the development and commercialization of a high-throughput nanochip to accelerate the diagnosis and treatment of breast, colon, prostate and other cancers.

From College of Nanoscale Science and Engineering, University at Albany 21 Jun 2013

Intezyne Technologies Acquires Niiki Pharma

Intezyne Technologies, a privately held drug development company dedicated to improving the treatment of cancer, announced it has acquired Niiki Pharma, of Hoboken, NJ, and Philadelphia, PA. Through the acquisition, Intezyne becomes a development-stage company with two compounds in early and mid-stage clinical development.

20 Jun 2013

Chemical Nanoengineering Innovation Holds Potential to Develop Light-Regulated Therapeutic Molecules

The scientific cooperation between chemists, biotechnologists and physicists from various Catalan institutes, headed by Pau Gorostiza, from the Institute for Bioengineering of Catalonia (IBEC), and Ernest Giralt, from the Institute for Research in Biomedicine (IRB Barcelona), has led to a breakthrough that will favor the development of light-regulated therapeutic molecules.

19 Jun 2013

Comprehensive Report on US Nanotechnology Drug Delivery Market

Research and Markets has announced the addition of the "Nanotechnology Drug Delivery Market in the US 2012-2016" report to their offering.

From Research and Markets 19 Jun 2013

Researchers Carve Nano-Volcanoes Using Light

Researchers from North Carolina State University have developed a method for creating “nano-volcanoes” by shining various colors of light through a nanoscale “crystal ball” made of a synthetic polymer. These nano-volcanoes can store precise amounts of other materials and hold promise for new drug-delivery technologies.

From North Carolina State University 15 Jun 2013